Top

Lung

Published in:

01-06-2012

Pulmonary Hypertension in Chronic Hypersensitivity Pneumonitis

Authors: Dirk S. Koschel, Carlos Cardoso, Bärbel Wiedemann, Gert Höffken, Michael Halank

Published in: Lung | Issue 3/2012

Abstract

Background

The purpose of this study was to evaluate the prevalence and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis and to examine the relationship between pulmonary function tests and pulmonary hypertension.

Methods

We conducted a retrospective review of 120 patients with hypersensitivity pneumonitis seen at two centers for pulmonary diseases over a 5-year interval and identified patients with chronic hypersensitivity pneumonitis for whom both pulmonary function tests and Doppler echocardiography data were available.

Results

Chronic hypersensitivity pneumonitis was identified in 83 patients and Doppler echocardiography data were available for 73 of them. Pulmonary hypertension (sPAP ≥ 50 mmHg) was detected in 14 patients (19%), and was associated with a greater risk of death (median survival = 23 months vs. 98 months; P = 0.003). Patients with pulmonary hypertension were older and had a significantly decreased PaO₂. There was a weak correlation between pulmonary function parameters and the underlying sPAP, with significance for FVC, FEV₁, and PaO₂ and inversely with PaCO₂.

Conclusions

Using Doppler echocardiography for evaluation, pulmonary hypertension seems to be common in patients with chronic hypersensitivity pneumonitis, significantly impacts survival, and correlates with FVC, FEV₁, and PaO₂ and inversely with PaCO₂.

Selmann M (2004) Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med 25:531–547CrossRef

Patel AM, Ryu JH, Reed CE (2001) Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 108:661–670PubMedCrossRef

Hanak V, Golbin JM, Hartmann TE, Ryu JH (2008) High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. Chest 134:133–138PubMedCrossRef

Vourlekis JS, Schwarz MI, Cherniak RM et al (2004) The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med 116:662–668PubMedCrossRef

Ohtani Y, Saiki S, Kitaichi M et al (2005) Chronic bird fancier’s lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 60:665–671PubMedCrossRef

Churg A, Sin DD, Everett D, Brown K, Cool C (2009) Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 33:1765–1770PubMedCrossRef

Behr J, Ryu JH (2008) Pulmonary hypertension in interstitial lung disease. Eur Respir J 31:1357–1367PubMedCrossRef

Shorr AF, Davies DB, Nathan SD (2003) Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 24:922–928CrossRef

Handa T, Nagai S, Miki S et al (2006) Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 129:1246–1252PubMedCrossRef

10.

Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD (2007) Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplantation. Eur Respir J 30:715–721PubMedCrossRef

11.

Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD (2007) Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 131:657–663PubMedCrossRef

12.

Lupi-Herrera E, Sandoval J, Bialostozky D et al (1981) Extrinsic allergic alveolitis caused by pigeon breeding at a high altitude (2240 meters). Am Rev Respir Dis 124:602–607PubMed

13.

Costabel U, Matthys H, Ruehle KH (1982) Pulmonary arterial hypertension in extrinsic allergic alveolitis (EAA). Am Rev Respir Dis 126:184PubMed

14.

Koschel D, Kolditz M, Höffken G, Halank M (2010) Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis. Med Sci Monit 16:CS 55–CS 57

15.

Yoshizawa Y, Ohtani Y, Hayakawa H, Sato A, Suga M, Ando M (1999) Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey. J Allergy Clin Immunol 103:315–320PubMedCrossRef

16.

McSharry C, Dye GM, Ismail T, Anderson K, Spiers EM, Boyd G (2006) Quantifying serum antibody in bird fancier’s hypersensitivity pneumonitis. BMC Pulm Med 6:16–24PubMedCrossRef

17.

Yock PG, Popp RL (1984) Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70:657–662PubMedCrossRef

18.

Galie N, Hoeper MM, Humbert M et al (2009) The guidelines for diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219–1263PubMedCrossRef

19.

Miller MR, Crapo R, Hankinson J et al (2005) General considerations for lung function testing. Eur Respir J 26:153–161PubMedCrossRef

20.

Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRef

21.

Wanger J, Clausen JL, Coates A et al (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522PubMedCrossRef

22.

Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735PubMedCrossRef

23.

Peduzzi P, Concato J, Feinstein AR, Holford TR (1995) Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. J Clin Epidemiol 48:1503–1510PubMedCrossRef

24.

Shorr AF, Helman DL, Davies DB, Nathan SD (2005) Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 25:783–788PubMedCrossRef

25.

Nadrous HF, Pellika PA, Krowka MJ et al (2005) Pulmonary hypertension in patients with idopathic pulmonary fibrosis. Chest 128:2393–2399PubMedCrossRef

26.

Lettieri CJ, Nathan SD, Barbnett SD, Ahmad S, Shorr AF (2006) Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129:746–752PubMedCrossRef

27.

Hoeper MM (2002) Pulmonary hypertension in collagen vascular disease. Eur Respir J 19:571–576PubMedCrossRef

28.

Chang B, Wigley FM, White B, Wise RA (2003) Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 30:2398–2405PubMed

29.

Launay D, Mouthon L, Hachulla E et al (2007) Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 34:1005–1011PubMed

30.

Trad S, Amoura Z, Beigelman C et al (2006) Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 54:184–191PubMedCrossRef

31.

Hachulla E, Gressin V, Guillevin L et al (2005) Early detection of pulmonary hypertension in systemic sclerosis. Arthritis Rheum 52:3792–3800PubMedCrossRef

32.

Mukerjee D, St George D, Coleiro B et al (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62:1088–1093PubMedCrossRef

33.

Ungerer RG, Tashkin DP, Furst D et al (1983) Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 75:65–74PubMedCrossRef

34.

Phung S, Strange G, Chung LP et al (2009) Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Intern Med J 39:682–691PubMedCrossRef

35.

Sahin H, Brown KK, Curran-Everett D et al (2007) Chronic hypersensitivity pneumonitis: CT features—comparison with pathologic evidence of fibrosis and survival. Radiology 244:591–598PubMedCrossRef

36.

Hamada K, Nagai S, Tanaka S et al (2007) Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131:650–656PubMedCrossRef

37.

McGoon M, Gutterman D, Steen V et al (2004) Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126:14S–34SPubMedCrossRef

38.

Homma A, Anzueto A, Peters JI et al (2001) Pulmonary artery systolic pressures estimated by echocardiogram vs cardiac catheterization in patients awaiting lung transplantation. J Heart Lung Transplant 20:833–839PubMedCrossRef

39.

Hinderliter AL, Willis PW 4th, Barst RJ et al (1997) Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation 95:1479–1486PubMed

40.

Brecker SJ, Gibbs JS, Fox KM, Yacoub MH, Gibson DG (1994) Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. Br Heart J 72:384–389PubMedCrossRef

41.

Arcasoy SM, Christie JD, Ferrari VA et al (2003) Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 167:735–740PubMedCrossRef

Title: Pulmonary Hypertension in Chronic Hypersensitivity Pneumonitis
Authors: Dirk S. Koschel
Carlos Cardoso
Bärbel Wiedemann
Gert Höffken
Michael Halank
Publication date: 01-06-2012
Publisher: Springer-Verlag
Published in: Lung / Issue 3/2012
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-011-9361-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Pulmonary Hypertension in Chronic Hypersensitivity Pneumonitis

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2012

Retrospective Analysis of 76 Immunocompetent Patients with Primary Pulmonary Cryptococcosis

Effect of Therapeutic Hyperoxia on Maximal Oxygen Consumption and Perioperative Risk Stratification in Chronic Obstructive Pulmonary Disease

Red Cell Distribution Width in Patients with Obstructive Sleep Apnea Syndrome

Novel Grading System for Quantifying Upper-Airway Obstruction on Sleep Endoscopy

Chronic Sinopulmonary Inflammatory Diseases in Adults with Undetectable Serum IgE in Inner-City Chicago: A Preliminary Observation

Serum Cystatin C and Emphysema: Results from the National Health and Nutrition Examination Survey (NHANES)

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page